Caregiver Burden in ALS Tied to Greater Anxiety, Disease Knowledge
The burden of caregiving is heavier for people who are anxious and reasonably knowledgeable about amyotrophic lateral sclerosis (ALS),…
Articles by Somi Igbene, PhD
Compound Works to Ease Brain Inflammation Driven by Glial Cells
A molecule that blocks the regulatory RNA protein HuR, called SRI-42127, strongly reduces brain inflammation driven by activated glial cells, key players in…
Age, Income Linked to Ventilation Use of ALS Patients in Korea
Age, socioeconomic status, and co-existing conditions are among the factors that can lead to a need for assisted ventilation in…
New PET Tracer May Better Capture Brain Inflammation in ALS
An imaging agent developed by Ashvattha Therapeutics can accurately detect brain inflammation caused by microglia, immune cells that play…
Advocacy Groups Invited to Try for Cytokinetics Communications Grants
Cytokinetics is accepting applications from advocacy groups working in cardiovascular and neuromuscular diseases, including amyotrophic lateral sclerosis (ALS), for…
NIH Awards PathMaker $371K to Advance Neuromodulation Therapy
PathMaker Neurosystems was awarded $371,000 from the National Institutes of Health (NIH) to advance its neuromodulation technology as a…
Health Canada to Review AMX0035 as ALS Treatment
Health Canada has agreed to review Amylyx Pharmaceuticals‘ application seeking approval of AMX0035 for the treatment of…